Korean Journal of Microbiology (미생물학회지)

The Microbiological Society of Korea (한국미생물학회)
권호 표지
DOI QR코드

DOI QR Code

Peptide H Reduces IL-6 Expression in Human Breast Cancer MDA-MB-231 Cells

인간 유방암 MDA-MB-231 세포에서 Peptide H에 의한 IL-6 발현 억제효과

  • Sung, Dae Il (Department of Biotechnology, The Research Institute for Basic Sciences, Hoseo University) ;
  • Park, Jameon (Department of Biotechnology, The Research Institute for Basic Sciences, Hoseo University) ;
  • Kim, Han Bok (Department of Biotechnology, The Research Institute for Basic Sciences, Hoseo University)
  • 성대일 (호서대학교 생명공학과, 기초과학연구소) ;
  • 박잠언 (호서대학교 생명공학과, 기초과학연구소) ;
  • 김한복 (호서대학교 생명공학과, 기초과학연구소)
  • Received : 2014.08.11
  • Accepted : 2014.09.23
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Chronic inflammation is involved in cancers, rheumatoid arthritis, and Crohn's disease. Inerleukin-6 (IL-6) plays major roles in inflammation. Chungkookjang, fermented soybean contains diverse peptides produced by cleavage of soybean proteins. The peptides can be bioactive compounds. Peptide (Gly-Val-Tyr-Tyr-Met-Tyr was purified from Chungkookjang, and modified to be 6mer H, Glu-Val-Tyr-Tyr-Met-Tyr (EVYYMY). Peptide H's activity to suppress IL-6 expression in a human breast cancer cell, MDA-MB-231 was determined. IL-6 Expression was reduced in the cell treated with peptide H 25 times less than controls which were not treated with peptide H. Proliferation of MDA-MB-231 cells was inhibited by peptide H, which is concentration-dependent. Blocking of IL-6 signals is known to be effective in reducing inflammation in rheumatoid arthritis, Crohn's disease, and cancers. Since peptide H can reduce inflammatory IL-6 expression, application of this study will contribute to drug development for diseases which are caused by excessive IL-6.

암, 류마티스, 크론병 등은 만성염증과 관련되어 있다. Interleukin-6 (IL-6)는 염증의 주요 매개인자이다. 청국장은 콩 발효식품으로 대두단백질이 분해되어 다양한 peptide가 생성되면서, 생리활성물질이 될 수 있다. 본 연구에서는 청국장에서 분리한 peptide (Gly-Val-Tyr-Tyr-Met-Tyr)를 가공한 6mer H, [(Glu-Val-Tyr-Tyr-Met-Tyr(EVYYMY)]가 유방암세포 MDA-MB-231에서 IL-6 발현을 억제할 수 있는지 여부를 결정하였다. MDA-MB-231 세포에 peptide H를 처리해 주면, IL-6 발현은 peptide를 처리하지 않은 control에 비해, 크게 억제되었으며, 세포의 성장은 농도의존적으로 억제되었다. 암 이외에, 류마티스, 크론병 등 만성염증 질환에서 IL-6 신호의 차단은 염증개선에 유효한 것으로 알려져 있다. Peptide H는 염증과 관련된 IL-6 발현의 감소효과가 있으므로, IL-6 관련 암, 류마티스, 크론병 등의 치료제 개발로 응용, 연결될 수 있을 것이다.

Keywords

References

  1. Berghe, W.V., Dijsselbloem, N., Vermeulen, L., Ndlovu, M.N., Boone, E., and Haegeman, G. 2006. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-${\kappa}B$ gene expression by soy isoflavones does not require estrogenic activity. Cancer Res. 66, 4852-4862. https://doi.org/10.1158/0008-5472.CAN-05-2957
  2. Coussens, L.M. and Werb, Z. 2002. Inflammation and cancer. Nature 420, 860-867. https://doi.org/10.1038/nature01322
  3. Grivennikov, S., Greten, F.R., and Karin, M. 2010. Immunity, inflammation, and cancer. Cell 140, 883-899. https://doi.org/10.1016/j.cell.2010.01.025
  4. Grivennikov, S. and Karin, M. 2011. Inflammatory cytokines in cancer: tumor necrosis factor and interleukin6 take the stage. Ann. Rheum. Dis. 70(Suppl1), i104-i108. https://doi.org/10.1136/ard.2010.140145
  5. Hwang, J.S., Yoo, H.J., Song, H.J., Kim, K.K., Chun, Y.J., Matsui, T., and Kim, H.B. 2011. Inflammation-related signaling pathways implicating TGFB are revealed in the expression profiling of MCF7 cell treated with fermented soybean, Chungkookjang. Nutr. Cancer 63, 645-652. https://doi.org/10.1080/01635581.2011.551987
  6. Korkaya, H., Kim, G., Davis, A., Malik, F., Henry, N.L., Ithimakin, S., Quraishi, A.A., Tawakkol, N., D'Angelo, R., Zen, Q., and et al. 2013. Activation of an IL-6 inflammatory loop mediates trastuzumab resistance in HER2 overexpressing breast cancers by expending the cancer stem cell population. Mol. Cell 47, 570-584.
  7. Lee, J.J., Lee, D.S., and Kim, H.B. 1999. Fermentation patterns of Chungkookjang and Kanjang by Bacillus licheniformis B1. Kor. J. Microbiol. 35, 296-301.
  8. Lin, W.W. and Karin, M. 2007. Cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183. https://doi.org/10.1172/JCI31537
  9. Mantovani, A. 2008. Cancer-related inflammation. Nature 454, 436-444. https://doi.org/10.1038/nature07205
  10. Matsui, T., Yoo, H.J., Hwang, J.S., Lee, D.S., and Kim, H.B. 2004. Isolation of angiotensin-1-converting enzyme inhibitory peptide from Chungkookjang. Kor. J. Microbiol. 40, 355-358.
  11. Milan, I.N., Singh, J.A., and Curtis, J.R. 2012. Systematic review of Tocilizumab for rheumatoid arthritis: a new biologic agent targeting the inteleukin-6 receptor. Clinic. Therap. 34, 788-802. https://doi.org/10.1016/j.clinthera.2012.02.014
  12. Ndlovu, M.N., Lint, C.V., Wesmael, K.V., Callebert, P., Chalbos, D., Haegeman, G., and Berghe, W.V. 2009. Hyperactivated NF-${\kappa}B$ and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell. Biol. 29, 5488-5504. https://doi.org/10.1128/MCB.01657-08

Cited by

  1. Peptide H reduces Il-6 expression in human breast cancer MDA-MB-231 cells vol.51, pp.3, 2015, https://doi.org/10.7845/kjm.2015.5028